A Phase 1b, Randomized, Open-label Study to Evaluate the Potential Pharmacokinetic and Pharmacodynamic Interactions Between RDEA3170 and Allopurinol in Adult Male Subjects With Gout
Phase of Trial: Phase I
Latest Information Update: 18 Sep 2015
At a glance
- Drugs Allopurinol (Primary) ; Verinurad (Primary)
- Indications Gout
- Focus Pharmacodynamics; Pharmacokinetics
- Sponsors Ardea Biosciences
- 14 Sep 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 14 Jul 2015 Planned End Date changed from 1 Jun 2015 to 1 Jul 2015 as reported by ClinicalTrials.gov record
- 14 May 2015 Planned End Date changed from 1 May 2015 to 1 Jun 2015 as reported by ClinicalTrials.gov record.